AEZS Old Financials

Based on the measurements of operating efficiency obtained from AEZS Old's historical financial statements, AEZS Old is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.
  
Understanding current and past AEZS Old Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AEZS Old's financial statements are interrelated, with each one affecting the others. For example, an increase in AEZS Old's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in AEZS Old's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AEZS Old. Check AEZS Old's Beneish M Score to see the likelihood of AEZS Old's management manipulating its earnings.

AEZS Old Stock Summary

AEZS Old competes with Pulmatrix, Moleculin Biotech, Adial Pharmaceuticals, Tonix Pharmaceuticals, and Jaguar Animal. Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina. Aeterna Zentaris is traded on NASDAQ Exchange in the United States.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address222 Bay Street,
New SymbolCSCI
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.zentaris.com
Phone843 900 3223
CurrencyUSD - US Dollar

AEZS Old Key Financial Ratios

AEZS Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AEZS Old's current stock value. Our valuation model uses many indicators to compare AEZS Old value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AEZS Old competition to find correlations between indicators driving AEZS Old's intrinsic value. More Info.
AEZS Old is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value AEZS Old by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in AEZS Stock

If you are still planning to invest in AEZS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AEZS Old's history and understand the potential risks before investing.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences